Abiomed
ABMD
#1105
Rank
NZ$29.96 B
Marketcap
$664.65
Share price
0.00%
Change (1 day)
N/A
Change (1 year)
Categories
Abiomed is an American medical devices company that develops and manufactures the circulatory support device Impella, the worldโ€™s smallest heart pump.

Earnings for Abiomed (ABMD)

Earnings in 2022 (TTM): NZ$0.54 Billion

According to Abiomed's latest financial reports the company's current earnings are NZ$1.07 Billion. In 2021 the company made an earning of NZ$0.33 Billion a decrease over its 2020 earnings that were of NZ$0.44 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Abiomed from 2013 to 2022

Annual earnings

Year Earnings Change
2022 (TTM) NZ$0.54 B65.26%
2021 NZ$0.33 B-25.49%
2020 NZ$0.44 B-19.62%
2019 NZ$0.55 B48.14%
2018 NZ$0.37 B51%
2017 NZ$0.24 B71.85%
2016 NZ$0.14 B41.79%
2015 NZ$0.10 B187.69%
2014 NZ$35.15 M126.26%
2013 NZ$15.53 M

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
NZ$0.27 B-53.39%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$3.98 B 568.89%๐Ÿ‡บ๐Ÿ‡ธ USA
-NZ$65.01 Million-110.92%๐Ÿ‡บ๐Ÿ‡ธ USA